| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_838bf936614275e07eaaae5ec38ec600 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-768
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-768 |
| filingDate |
2018-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94f18e4a7db81d35689fb7e58b24644c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e09753fbb9c7cad414bef26fde75deb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c5c6b86fe0cf94bc2d5e3599a71795d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b63f4ce0238082d565cc8a5ea5c396a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60ab596427523f676c0e6cbd59ef3fad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad42c4b52a1d688c669e50ec73184de1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d5bc9c7482d9d63a488ffc3de368d51 |
| publicationDate |
2019-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201929882-A |
| titleOfInvention |
Use of E3 ligase inhibitor and oncolytic virus for the preparation of antitumor drugs |
| abstract |
The invention belongs to the field of biomedicine and relates to the use of an E3 ligase inhibitor and an oncolytic virus for preparing an antitumor drug. The present invention finds for the first time that an E3 ligase inhibitor can be used to prepare an oncolytic virus antitumor synergist. The invention also relates to a pharmaceutical composition comprising an E3 ligase inhibitor and an oncolytic virus; a pharmaceutical kit comprising an E3 ligase inhibitor and an oncolytic virus; and an E3 ligase inhibitor and an oncolytic virus in treating tumors--particularly It is the use in tumors that are not sensitive to the oncolytic virus. |
| priorityDate |
2017-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |